GRACE DIEHL: Open Payments
NPI 1649365024 · GROVE CITY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 53 payments from 18 companies in 2025. Trend: 2023 $511 · 2024 $1,015 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $183 |
| Novo Nordisk Inc | 12 | $166 |
| Amgen Inc. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| PFIZER INC. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $24 |
Products named: MOUNJARO, Ozempic, TRELEGY ELLIPTA, JARDIANCE, REXULTI, OTEZLA, PREVNAR 20, Rybelsus.
Industry payments across PA — which companies pay providers there.
